Aptus Clinical receives £150K for business expansion

Contract research organisation Aptus Clinical has received £150,000 from the Northern Powerhouse Investment Fund (NPIF) – FW Capital Debt Finance, to help it expand.

The company, based in Alderley Park, was founded by three former employees of AstraZeneca and has since grown to a team of 48 within four years.

The funds have boosted the company’s expansion plans and will allow for additional investment to be made into infrastructure, staff and customer capabilities. Aptus Clinical has a particular focus in oncology, rare diseases and cellular therapies, specialising in providing biotech companies with drug development expertise.

The company has recently expanded its leadership team in the hope of driving its four core functions of commercial, corporate & clinical governance, clinical services and business services. More so, it has also moved within Alderley Park to a larger office space to accommodate its current and future growth.

Aptus Clinical CEO Steve McConchie said: “We are delighted with the support from the Northern Powerhouse Investment Fund and FW Capital, and the new additions to our team, restructuring and office move to our larger new location in Alderley Park are all a reflection of the incredible work being carried out by our team.”

FW Capital senior investment executive Simon Berry added: “Aptus is run by a very strong management team that includes the scientific expertise of its founders and the business acumen of the additional non-exec board members.

“We are very passionate about supporting businesses in the biotech space and we have a good understanding of the industry. We have invested in several companies at Alderley Park and other science hubs and we’d really like to encourage more businesses in this sector to speak to us if they need finance.”